In developmentCited answers over your own documents

Every claim,traced to its source.

Ask DocuMind about the contracts, policies and filings your team owns. Every sentence of the answer keeps a thread to the exact passage behind it — and when the documents don't say, neither does DocuMind.

Opens your email app — we write once, when cited answers go live.

How it works
HLHelix Legal
Ask
ScopeMergers · Acme/Sterling5 docs · 1,764 chunks · K=12

Ask anything across 5 documents…

Acme-Sterling Merger Agreementp. 47

Article IV · Representations and Warranties of the Company

4.17 Brokers. No broker, finder or investment banker is entitled to any fee in connection with the Merger based on arrangements made by the Company. 4.18 Material Adverse Effect. Section 4.18. “Material Adverse Effect” shall not include any effect arising from (a) general economic, regulatory or political conditions; (b) acts of war, terrorism, or pandemics; (c) any change in GAAP or applicable Law, in each case as in effect on the date of this Agreement, and (d) any failure to meet internal projections.

“Company Material Adverse Effect” shall be determined without regard to any change in the market price or trading volume of the Company Common Stock, provided that the underlying causes of such change may be taken into account.

4.20 Absence of Certain Changes. Since the Balance Sheet Date, the Company has conducted its business in the ordinary course consistent with past practice in all material respects.

chunk #318 · sim 0.912cited
Acme-Sterling Merger Agreementp. 48

Article IV · Representations and Warranties of the Company

(e) the announcement or pendency of the Merger; provided, however, that any effect described in clauses (a) through (e) shall be taken into account to the extent such effect disproportionately affects the Company relative to other Persons operating in the relevant industry, and then only to the extent of such incremental disproportionate impact.

4.20 Absence of Certain Changes. Since the Balance Sheet Date, the Company has conducted its business in the ordinary course consistent with past practice in all material respects.

“Company Material Adverse Effect” shall be determined without regard to any change in the market price or trading volume of the Company Common Stock, provided that the underlying causes of such change may be taken into account.

chunk #322 · sim 0.884cited
Sterling 10-K (2025)p. 31

Item 1A · Risk Factors

Supply chain concentration. We rely on two contract manufacturers located in Suzhou, China for approximately 64% of our finished active pharmaceutical ingredient supply. A disruption at either facility would materially affect our ability to deliver product, and qualifying an alternative site could take eighteen months or longer.

We have not qualified a second source for three of our five commercial products. Qualification requires regulatory filings in each market in which the product is sold.

Changes in trade policy, including tariffs on pharmaceutical inputs, could increase our cost of goods and reduce our gross margin.

chunk #142 · sim 0.841cited
Acme-Sterling Merger Agreementp. 49

Article IV · Representations and Warranties of the Company

4.19 Antitrust Approvals. The Company shall use reasonable best efforts to obtain each Antitrust Approval. The following shall not in any event be excluded from the definition of “Material Adverse Effect”: (i) the failure to obtain any Antitrust Approval, or (ii) the issuance of any injunction relating thereto, whether or not such failure or injunction was foreseeable.

4.20 Absence of Certain Changes. Since the Balance Sheet Date, the Company has conducted its business in the ordinary course consistent with past practice in all material respects.

chunk #325 · sim 0.812cited

Design preview — sample workspace, documents and citations; answers are scripted until retrieval ships.Dashed markers are samples; solid markers cite this page.

Most answers sound right. Hold one up to the light.

Move the lens across both answers to the same question. It shows what each sentence stands on.

A confident paragraphChecked 0 of 3

The MAE clause excludes broad market-wide effects such as economic conditions, war and pandemics, and generally would not cover risks specific to Sterling. Regulatory challenges are typically treated as deal risk rather than MAE events.

Illustrative. Written to read well, with nothing underneath.

0 of 3 claims have a source.No source.Contradicted: p.48 says the opposite.Contradicted: p.49 says the opposite.
DocuMindChecked 0 of 3

The agreement excludes general economic or political conditions, pandemics, acts of war, and changes in law1 — but pulls them back in when they hit Sterling harder than its peers2. And a failed antitrust approval is not carved out at all3.

Design preview. Each marker opens its passage.

3 of 3 claims have a source.Source 1: p.47 · chunk #318 · 0.912.Source 2: p.48 · chunk #322 · 0.884.Source 3: p.49 · chunk #325 · 0.812.

Watch a page become evidence.

1/5ReadLive

Text comes out of the verified file, and the run writes a checkpoint.

We cite our own claims, too.

Engineering promises are claims like any other. Each one below quotes the line in our repository that commits us to it — and says whether it runs yet.

3Product gate D02, statusLive

…verified size/checksum, and upload completion as the one route that promotes the staged object. A document becomes durable at verification, not at create.

apps/api/docs/product.md · quoted verbatim

Seven slices shipped. Retrieval is being built now.

DocuMind is pre-release. Each slice was proven with tests on the real stack before the next began — that is also why this page can say exactly what runs today.

  1. S1Workspaces
  2. S2Revisions & runs
  3. S3Verified upload
  4. S4Job fencing
  5. S5Extraction
  6. S6Chunking
  7. S7Embedding
  8. S8Index & retrievalIn build
  9. NextAsk · sign-in · modelsPlanned

Ask your documents. Then check them.

There is no sign-up yet. Tell us what you would ask your own documents, and we will write once — when cited answers go live.

hello@documind.si

Sources for this page

Every marker above, quoted from the repository
  1. 1

    “Citations name exact revision + location.”

    apps/api/docs/product.md · Product gate D01 · Contract written

  2. 2

    “Evidence/citation validation; insufficient-evidence behavior”

    apps/api/docs/product.md · Product gate D07 · Contract written

  3. 3

    “A document becomes durable at verification, not at create.”

    apps/api/docs/product.md · Product gate D02, status · Live

  4. 4

    “No semantic-retrieval claim, no quality claim, and no grounded-answer claim may rest on those vectors.”

    apps/api/docs/slice-8.md · Slice 8 entry contract · Live

  5. 5

    “Revocation stops serving at once — a removed member sees nothing.”

    apps/api/docs/slice-8.md · Slice 8 entry contract · Contract written

  6. 6

    “A stuck run is found without a person: the watchdog fails it”

    apps/api/docs/product.md · Product gate D08, status · Live

  7. 7

    “for a given DocumentRevision, at most one ProcessingRun may be active”

    docs/adr/0030-one-active-processing-run.md · ADR 0030 · Live

  8. 8

    “worker events are key=value identity lines with no text, vectors, email, URLs or credentials”

    apps/api/docs/product.md · Product gate D08, status · Live

  9. 9

    “keep serving the last good generation, marked as the previous version when it is.”

    docs/adr/0039-serving-run-checkpoint-reuse.md · ADR 0039 · Contract written

  10. 10

    “retrieval and Ask come after Slice 8.”

    apps/api/docs/product.md · Slice progression · In build

DDocuMinddocumind.siSample workspaces, documents and answers on this page are design previews.© 2026 DocuMind